<DOC>
	<DOCNO>NCT00837720</DOCNO>
	<brief_summary>This open label , non-interventional study show efficacy antihypertensive treatment Atacand hypertensive patient . Efficacy evaluate base difference systolic diastolic blood pressure baseline follow-up visit .</brief_summary>
	<brief_title>Evaluation Atacand® ( Candesartan ) Daily Medical Practice</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>patient arterial hypertension prescribe Atacand accord physician 's judgement , irrespective inclusion study hypersensitivity candesartan ingredient Atacand liver function impairment and/or cholestasis severe renal insufficiency woman childbearing potential use appropriate contraceptive measure , pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>Atacand®</keyword>
	<keyword>candesartan</keyword>
</DOC>